Skip to main content

Table 4 Adverse events during treatment

From: Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study

Adverse events

IVMP

Tacrolimus

p value

Pain (n, %)

1 (3.4%)

0

1.000

Insomnia (n, %)

1 (3.4%)

1 (3.6%)

1.000

Tremors (n, %)

0

1 (3.6%)

0.491

Hyperuricemia (n, %)

1 (3.4%)

2 (7.1%)

0.975

Hyperlipidemia (n, %)

0

1 (3.6%)

0.491

Elevated blood glucose (n, %)

2 (6.9%)

2 (7.1%)

1.000

Gastrointestinal symptoms (n, %)

0

4 (14.3%)

0.111

  1. IVMP, intravenous methylprednisolone